• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2010 Fiscal Year Final Research Report

Molecular pathological evaluation of therapeutic effect using PET/CT in patients with esophageal cancer

Research Project

  • PDF
Project/Area Number 20591465
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Radiation science
Research InstitutionKurume University

Principal Investigator

ISHIBASHI Masatoshi  Kurume University, 医学部, 教授 (20168256)

Co-Investigator(Kenkyū-buntansha) KAIDA Hayato  久留米大学, 医学部, 助教 (40299425)
KURATA Seiji  久留米大学, 医学部, 助教 (80268888)
KAGE Masayoshi  久留米大学, 医学部, 教授 (80148840)
YAMANA Hideaki  久留米大学, 医学部, 教授 (30140669)
FUJII Teruhiko  久留米大学, 医学部, 准教授 (50199288)
FUJITA Hiromasa  久留米大学, 医学部, 教授 (90156878)
HAYABUCHI Naofumi  久留米大学, 医学部, 教授 (20108731)
Project Period (FY) 2008 – 2010
Keywords食道癌 / PET / CT / FDG / GLUT family / VEGF / GLUT 1 / GLUT 3
Research Abstract

To examine the relationship between glucose transporter (GLUT-1) and vasoendothelial growth factor (VEGF) expression and fluorine-18-fluorodeoxyglucose (^<18>F-FDG) uptake in esophageal squamous cell cancer (ESCC) patients. Methods : Fifty-seven patients were included in this study. The patients consisted of 52 males and 5 females. ^<18>F-FDG positron emission tomography/computed tomography (PET)/CT was performed prior to the surgery. Immunohistochemistry (IHC) was performed using postoperative histopathological specimens. The estimation of IHC was conducted using scoring analysis. We investigated the correlations between maximum standardized uptake value (SUV max) and GLUT-1/VEGF expressions/pathological tumor length (p-tumor length), and the relationships between pathological T (p-T) stage and GLUT-1/VEGF expressions/SUV max and between lymph node metastasis (p-N) stage and GLUT-1/VEGF expressions/SUV max. Results : SUV max were significantly correlated with GLUT-1 expressions and p-tumor length [GLUT-1 : r=0.475, p < 0.001, p-tumor length : r=0.475, p <0.001]. SUV max of the primary tumor had a significant relationship with p-T stage, p-N stage, and VEGF expression [p-T stage : p <0.001, p-N stage : p=0.037, VEGF expression : p=0.009]. There was a statistically significant difference between GLUT-1 expression and p-T stage/VEGF expression but not p-N stage (p-T stage : p=0.012, VEGF expression : p=0.01, p-N stage : p=0.572). VEGF expression had a significant relationship with p-T stage but not p-N stage (p-T stage : p=0.032, p-N stage : p=0.763). Conclusion : Our data indicate that 18F-FDG uptake can be determined by GLUT-1and VEGF. SUV max would have a connection with the tumor progression and lymph node metastasis.

  • Research Products

    (4 results)

All 2010 2009 Other

All Presentation (3 results) Remarks (1 results)

  • [Presentation] The relationship between biologic factor and 18F-FDG uptake in esophageal squamous cell cancer patients.2010

    • Author(s)
      小林真衣子, 石橋正敏, et al.
    • Organizer
      Annual Congress of Australia and New Zealand Society of Nuclear Medicine 2010
    • Place of Presentation
      Auckland, New Zealand
    • Year and Date
      2010-04-23
  • [Presentation] 分子病理学的手法を用いての食道癌へのFDG集積の特性解析2009

    • Author(s)
      小林真衣子,甲斐田勇人,石橋正敏,他
    • Organizer
      第49回日本核医学会学術総会
    • Place of Presentation
      旭川
    • Year and Date
      20091001-20091003
  • [Presentation] 他1分子病理学的手法を用いての食道癌へのFDG集積の特性解析2009

    • Author(s)
      小林真衣子、甲斐田勇人、石橋正敏
    • Organizer
      第45回日本核医学会九州地方会
    • Place of Presentation
      佐賀
    • Year and Date
      2009-02-14
  • [Remarks] ホームページ等

URL: 

Published: 2012-01-26   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi